Bioventus Inc. Liabilities and Equity in USD from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Bioventus Inc. quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q3 2025.
  • Bioventus Inc. Liabilities and Equity for the quarter ending September 27, 2025 was $702M, a 8.82% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)

Bioventus Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $702M -$67.9M -8.82% Sep 27, 2025 10-Q 2025-11-04
Q2 2025 $707M -$85.4M -10.8% Jun 28, 2025 10-Q 2025-08-06
Q1 2025 $691M -$103M -12.9% Mar 29, 2025 10-Q 2025-05-06
Q4 2024 $728M -$83M -10.2% Dec 31, 2024 10-Q 2025-11-04
Q3 2024 $769M -$41.6M -5.13% Sep 28, 2024 10-Q 2024-11-05
Q2 2024 $792M -$44.8M -5.35% Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $794M -$93.2M -10.5% Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $811M -$562M -40.9% Dec 31, 2023 10-K 2025-03-11
Q3 2023 $811M -$587M -42% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $837M -$372M -30.8% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 $887M -$310M -25.9% Apr 1, 2023 10-Q 2023-05-16
Q4 2022 $1.37B +$147M +12% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $1.4B +$743M +114% Oct 1, 2022 10-Q 2022-11-21
Q2 2022 $1.21B +$562M +86.9% Jul 2, 2022 10-Q 2022-08-12
Q1 2022 $1.2B +$554M +86.2% Apr 2, 2022 10-Q 2022-05-11
Q4 2021 $1.23B +$731M +148% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $655M Oct 2, 2021 10-Q 2021-11-10
Q2 2021 $647M Jul 3, 2021 10-Q 2021-08-11
Q1 2021 $643M Apr 3, 2021 10-Q 2021-05-13
Q4 2020 $494M Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.